| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James P. Boylan | Director | Oct 10, 2024 | |||
| Richard A. Young | Director | Oct 15, 2024 | |||
| Ravi I. Thadhani | Director | Oct 10, 2024 | |||
| Paula Ragan | Director | Oct 10, 2024 | |||
| Michael J. Higgins | Director | Oct 10, 2024 | |||
| Ingo Chakravarty | Director | Oct 10, 2024 | |||
| Steven H. Holtzman | Director | Oct 15, 2024 | |||
| David Bumcrot | Chief Scientific Officer | Oct 10, 2024 | |||
| Andrew J. Schwab | Director, 10%+ Owner | Oct 15, 2024 | |||
| Kelly Gold | Chief Financial Officer | Oct 10, 2024 | |||
| Josh Mandel-Brehm | Chief Executive Officer, Director | Oct 15, 2024 | |||
| Yuri Maricich | Chief Medical Officer | Oct 10, 2024 | |||
| 5AM Partners VI, LLC | 10%+ Owner | Oct 15, 2024 | |||
| Amir Nashat | Director, 10%+ Owner | Oct 15, 2024 | |||
| Polaris Management Co. VII, L.L.C. | 10%+ Owner | Oct 15, 2024 | |||
| AH Equity Partners Bio I, L.L.C. | 10%+ Owner | Oct 15, 2024 | |||
| Polaris Partners GP X, L.L.C. | 10%+ Owner | Oct 15, 2024 | |||
| Northpond Ventures GP II, LLC | 10%+ Owner | Oct 15, 2024 | |||
| Enavate Sciences GP, LLC | 10%+ Owner | Oct 15, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|